Press Releases
AstraZeneca announces positive results from benralizumab phase III programme...
AstraZeneca announced that benralizumab, a potential new medicine and anti-eosinophil monoclonal antibody, was well tolerated and achieved the primary endpoint in two pivotal Phase III...
Press Releases
Otsuka Holdings Announces Collaboration with ReCor Medical for Commercialization...
Otsuka Holdings Co Ltd announced the signing of a development and commercialization agreement with ReCor Medical Inc. together with an additional investment. As part of...
Press Releases
Biogen Announces Collaboration with University of Pennsylvania on Multiple...
Visionary, up to $2 billion multi-year alliance to focus on development of new gene therapy and gene editing technologies and create a therapeutic platform...
Press Releases
Immunosup pressant CellCept Obtained Approval for Additional Indication of...
Chugai Pharmaceutical Co Ltd. announced that it obtained a supplemental approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) on May 13, 2016,...
Press Releases
Chugai Pharmaceutical Co Ltd. to Take Part in “Relay...
Chugai Pharmaceutical Co Ltd announced that its co-sponsorship of “Relay for Life Japan” (Organizer: Japan Cancer Society etc.), a charity activity aiming to support cancer...
Press Releases
Pfizer reports Results From Two Phase 3 TRUMENBA (Meningococcal...
Pfizer Inc announced results of two Phase 3 studies demonstrating the immunogenicity of TRUMENBA® (Meningococcal Group B Vaccine) against invasive meningococcal B (MnB) strains representative...
Press Releases
Pfizer Announces Results From Two Phase 3 TRUMENBA ...
Pfizer Inc announced results of two Phase 3 studies demonstrating the immunogenicity of TRUMENBA® (Meningococcal Group B Vaccine) against invasive meningococcal B (MnB) strains representative...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.